Cost-Effectiveness of a Blood-Based Biomarker Compared to Endomyocardial Biopsy for the Diagnosis of Acute Allograft Rejection

Journal of Heart and Lung Transplantation - Netherlands
doi 10.1016/j.healun.2016.01.145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Heparan Sulfate Is a Plasma Biomarker of Acute Cellular Allograft Rejection

PLoS ONE
Multidisciplinary
2018English

Endomyocardial Biopsy in Diagnosis of Cardiomyopathies.

Heart
Cardiovascular MedicineCardiology
1971English

Development and Clinical Validity of a Novel Blood-Based Molecular Biomarker for Sub-Clinical Acute Rejection Following Kidney Transplant

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

The Problem of Heart Transplant Rejection and Ways of Optimizing the Assessment of Endomyocardial Biopsy Results

Journal of Clinical Practice
2017English

Editorial: Diagnosis of Cardiac Sarcoidosis – What Is the Role of Endomyocardial Biopsy?

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2015English

Native T1 Mapping in the Diagnosis of Cardiac Allograft Rejection

JACC: Cardiovascular Imaging
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2019English

GC/MS-based Urine Metabolomics Analysis of Renal Allograft Recipients With Acute Rejection

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Antibody-Mediated Renal Allograft Rejection: Diagnosis and Pathogenesis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Endomyocardial Biopsy: The Balance of Success and Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy